Literature DB >> 12951110

Synthesis and anthelmintic activity of cyclohexadepsipeptides with (S,S,S,R,S,R)-configuration.

Peter Jeschke1, Jordi Benet-Buchholz, Achim Harder, Winfried Etzel, Michael Schindler, Gerhard Thielking.   

Abstract

The (S,S,S,R,S,R)-configurated cyclohexadepsipeptides (CHDPs) represent novel enniatin derivatives with strong in vivo activity against the parasitic nematode Haemonchus contortus Rudolphi in sheep. 2D NMR spectroscopic analysis revealed for the major conformation the asymmetric conformer, containing a cis-amide bond between C(alpha) protons of neighbouring 2-hydroxy-(S)-carboxylic acid and N-methyl-(S)-amino acid. The absolute configuration of the novel CHDPs was determined by X-ray crystallography. A correlation between the major conformer and its anthelmintic activity was found. Here, we report on a simple total synthetic pathway for this particular type of CHDPs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12951110     DOI: 10.1016/s0960-894x(03)00688-7

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

Review 1.  Revisiting the enniatins: a review of their isolation, biosynthesis, structure determination and biological activities.

Authors:  Arlene A Sy-Cordero; Cedric J Pearce; Nicholas H Oberlies
Journal:  J Antibiot (Tokyo)       Date:  2012-09-19       Impact factor: 2.649

2.  Comparative Structure-Activity Analysis of the Antimicrobial Activity, Cytotoxicity, and Mechanism of Action of the Fungal Cyclohexadepsipeptides Enniatins and Beauvericin.

Authors:  Hamza Olleik; Cendrine Nicoletti; Mickael Lafond; Elise Courvoisier-Dezord; Peiwen Xue; Akram Hijazi; Elias Baydoun; Josette Perrier; Marc Maresca
Journal:  Toxins (Basel)       Date:  2019-09-03       Impact factor: 4.546

Review 3.  Distribution, pathogenicity and disease control of Fusarium tricinctum.

Authors:  Yun Wang; Ruoyu Wang; Yuexia Sha
Journal:  Front Microbiol       Date:  2022-07-26       Impact factor: 6.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.